Kimberlee C Drapkin Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

Kimberlee C Drapkin is Director of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 12,800 shares of ABOS, which is worth approximately $15,360. The most recent transaction as insider was on Jun 04, 2025, when has been sold 12,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

n/a 3M change

n/a 12M change

Total Value Held $15,360

Kimberlee C Drapkin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 04 2025	BUY Grant, award, or other acquisition	-	12,800 Added 50.0%	12,800 Common Stock

Also insider at

JNCE

Jounce Therapeutics, Inc. Healthcare

President, CFO and Treasurer

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

GRPH

Graphite Bio, Inc. Healthcare

Director

ELYM

Eliem Therapeutics, Inc. Healthcare

KCD